🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shijun Zhang

Guangdong Academy of Sciences

ORCID: 0000-0001-9732-5925

Also affiliated with Institute of Zoology

MedicineBiochemistry, Genetics and Molecular BiologyComputer ScienceNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.104Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An Informatics Bridge to Improve the Design and Efficiency of Phase I Clinical Trials for Anticancer Drug Combinations

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0160
Top 78%
0.104DataRank
Top 78%1 citations

Lai Wei, Shijun Zhang, Lijun Cheng, Aditi Shendre, Williams Carson +5 more

Papers

Driven by 17 papers — median percentile 22. Top paper: “Novel Positron Emission Tomography Radiotracers for Imaging Mitochondrial Complex I”.

Novel Positron Emission Tomography Radiotracers for Imaging Mitochondrial Complex I

ACS Chemical Neuroscience(2021)10.1021/acschemneuro.1c00297
N/A
0.312DataRank · unranked
7 citations

Yiming Xu, Savannah Biby, Ping Bai, Yan Liu, Can Zhang +3 more

An Informatics Bridge to Improve the Design and Efficiency of Phase I Clinical Trials for Anticancer Drug Combinations

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0160
Top 78%
0.104DataRank
Top 78%1 citations

Lai Wei, Shijun Zhang, Lijun Cheng, Aditi Shendre, Williams Carson +5 more

Discovery of carbon-11 labeled sulfonamide derivative: A PET tracer for imaging brain NLRP3 inflammasome

Bioorganic & Medicinal Chemistry Letters(2021)10.1016/j.bmcl.2021.127777
N/A
0DataRank · unranked
23 citations

Yiming Xu, Hallie Blevins, Yu Lan, Yan Liu, Gengyang Yuan +8 more

Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 Diabetes

ACS Pharmacology & Translational Science(2021)10.1021/acsptsci.1c00028
N/A
0DataRank · unranked
23 citations

Paul Velander, Anne M. Brown, Yao Wang, Dongmin Liu, David R. Bevan +3 more

Structural understanding of 5-(4-hydroxy-phenyl)-N-(2-(5-methoxy-1H-indol-3-yl)-ethyl)-3-oxopentanamide as a neuroprotectant for Alzheimer’s disease

Bioorganic & Medicinal Chemistry Letters(2021)10.1016/j.bmcl.2021.128081
N/A
0DataRank · unranked
3 citations

Jakob Green, Yuqi Jiang, Yiming Xu, Glen E. Kellogg, Shijun Zhang +1 more

The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases

Frontiers in Aging Neuroscience(2022)10.3389/fnagi.2022.879021
N/A
0DataRank · unranked
551 citations

Yiming Xu, Savannah Biby, Shijun Zhang, Hallie Blevins

Development of sulfonamide-based NLRP3 inhibitors: Further modifications and optimization through structure-activity relationship studies

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114468
N/A
0DataRank · unranked
24 citations

Yulong Xu, Hallie Blevins, Chunqing Guo, Savannah Biby, Xiang‐Yang Wang +3 more

Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activities

Pharmacological Research(2022)10.1016/j.phrs.2022.106409
N/A
0DataRank · unranked
16 citations

Ling Wu, Sherry B. Hildreth, Nancy J. Vogelaar, Biswarup Mukhopadhyay, Richard F. Helm +3 more

Mechanistic Insights of Sulfonamide‐Based NLRP3 Inhibitors for the Treatment of Neurodegenerative Diseases

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r3734
N/A
0DataRank · unranked
4 citations

Yiming Xu, Savannah Biby, Shijun Zhang, Hallie Blevins

A patent review of NLRP3 inhibitors to treat autoimmune diseases

Expert Opinion on Therapeutic Patents(2023)10.1080/13543776.2023.2239502
N/A
0DataRank · unranked
14 citations

Savannah Biby, Baljit Kaur, Shijun Zhang, Yiming Xu

Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing Scaffold

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c01782
N/A
0DataRank · unranked
14 citations

Yulong Xu, Savannah Biby, Baljit Kaur, Yan Liu, Frederick A. Bagdasarian +6 more

Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors

Advances in pharmacology(2024)10.1016/bs.apha.2024.10.004
N/A
0DataRank · unranked
11 citations

Savannah Biby, Jannatun Nayem Namme, Sayaji More, Yiming Xu, Shijun Zhang +1 more

Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 Inflammasome

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.4c00512
N/A
0DataRank · unranked
6 citations

Prasenjit Mondal, Yiming Xu, Ashley Gomm, Baljit Kaur, Jannatun Nayem Namme +5 more

Characterization of a small molecule inhibitor of the NLRP3 inflammasome and its potential use for acute lung injury

Bioorganic Chemistry(2024)10.1016/j.bioorg.2024.107562
N/A
0DataRank · unranked
5 citations

Savannah Biby, Chunqing Guo, Zheng Liu, Jinyang Cai, Xiangyang Wang +2 more

Catechol-Containing Compounds are a Broad Class of Protein Aggregation Inhibitors: II. Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in HIP Rats

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.13.873687
N/A
0DataRank · unranked
2 citations

Paul Velander, Anne M. Brown, Yao Wang, Dongmin Liu, David R. Bevan +3 more

Characterization of a novel PET radioligand for mitochondrial complex I in nonhuman primate

Nuclear Medicine and Biology(2025)10.1016/j.nucmedbio.2025.108993
N/A
0DataRank · unranked
1 citations

Yiming Xu, Frederick A. Bagdasarian, Tewodros Mulugeta Dagnew, Hua Cheng, Yanli Wang +7 more

Catechol-Containing Compounds are a Broad Class of Protein Aggregation Inhibitors: Redox State is a Key Determinant of the Inhibitory Activities

Research Square(2020)10.21203/rs.3.rs-122859/v1
N/A
0DataRank · unranked
1 citations

Ling Wu, Sherry B. Hildreth, Nancy J. Vogelaar, Biswarup Mukhopadhyay, Shijun Zhang +3 more